Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-23

Clinical Trial Update: START: Swiss Taxotere Alopecia Prevention Trial [NA]

View source ↗

Summary

This completed trial evaluated whether Taxotere (docetaxel) can prevent alopecia in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms, Alopecia | NA | Status: COMPLETED